Medtronic PLC
DUS:2M6

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
DUS:2M6
Watchlist
Price: 85.78 EUR 1.22% Market Closed
Market Cap: €114.1B

Operating Margin

19.4%
Current
Declining
by 0.2%
vs 3-y average of 19.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19.4%
=
Operating Income
$6.8B
/
Revenue
$34.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19.4%
=
Operating Income
€6.8B
/
Revenue
$34.8B

Peer Comparison

Country Company Market Cap Operating
Margin
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
17.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.8B USD
Loading...

Market Distribution

Higher than 86% of companies in Ireland
Percentile
86th
Based on 294 companies
86th percentile
19.4%
Low
-5 292.3% — 0.1%
Typical Range
0.1% — 13.7%
High
13.7% — 178.8%
Distribution Statistics
Ireland
Min -5 292.3%
30th Percentile 0.1%
Median 9.5%
70th Percentile 13.7%
Max 178.8%

Medtronic PLC
Glance View

In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.

2M6 Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
19.4%
=
Operating Income
$6.8B
/
Revenue
$34.8B
What is Medtronic PLC's current Operating Margin?

The current Operating Margin for Medtronic PLC is 19.4%, which is below its 3-year median of 19.6%.

How has Operating Margin changed over time?

Over the last 3 years, Medtronic PLC’s Operating Margin has decreased from 20.5% to 19.4%. During this period, it reached a low of 18.9% on Jul 26, 2024 and a high of 20.5% on Oct 28, 2022.

Back to Top